|
ASB7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03869999999751E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.43110000000191E-05 |
| Normal-vs-Stage2 |
2.406400E-01 |
| Normal-vs-Stage3 |
1.234180E-02 |
| Normal-vs-Stage4 |
8.733600E-02 |
| Stage1-vs-Stage2 |
3.664600E-01 |
| Stage1-vs-Stage3 |
8.970800E-01 |
| Stage1-vs-Stage4 |
9.927000E-01 |
| Stage2-vs-Stage3 |
5.051400E-01 |
| Stage2-vs-Stage4 |
5.807200E-01 |
| Stage3-vs-Stage4 |
9.417800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.05700000000175E-05 |
| Normal-vs-AfricanAmerican |
8.015400E-03 |
| Normal-vs-Asian |
1.997950E-03 |
| Caucasian-vs-AfricanAmerican |
5.710200E-01 |
| Caucasian-vs-Asian |
5.468400E-01 |
| AfricanAmerican-vs-Asian |
4.065000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56063999999789E-05 |
| Normal-vs-Female |
3.657800E-02 |
| Male-vs-Female |
1.270040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.605700E-02 |
| Normal-vs-Extreme_Weight |
1.14440000031912E-07 |
| Normal-vs-Obese |
3.145600E-02 |
| Normal-vs-Extreme_Obese |
3.965700E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.138240E-01 |
| Normal_Weight-vs-Obese |
7.217000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.923800E-01 |
| Extreme_Weight-vs-Obese |
4.412300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.620800E-01 |
| Obese-vs-Extreme_Obese |
4.734400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.55399999999651E-05 |
| Normal-vs-Age(41-60Yrs) |
8.883900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.33309999999598E-05 |
| Normal-vs-Age(81-100Yrs) |
1.193610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.112000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.408400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.748400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.761800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.630750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.215400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.972200E-04 |
| Normal-VS-Type2 PRCC |
1.201030E-03 |
| Normal-VS-KIRP CIMP |
3.84749999999823E-05 |
| Normal-VS-Unclassified PRCC |
1.586180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.368200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.893600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.485000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.756240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.508200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.986400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9347999996876E-07 |
| Normal-vs-N1 |
1.919770E-01 |
| Normal-vs-N2 |
1.603020E-04 |
| N0-vs-N1 |
7.943700E-02 |
| N0-vs-N2 |
2.685400E-01 |
| N1-vs-N2 |
1.317440E-01 |
|
|
